AUTUMN HIRRILL: Open Payments
NPI 1790268589 · BAYTOWN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,588 in 74 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $720 · 2025 $1,588
Food & beverage: $1,588
| Company | Payments | Amount |
|---|---|---|
| Tris Pharma Inc | 14 | $274 |
| ABBVIE INC. | 16 | $269 |
| Axsome Therapeutics, Inc. | 7 | $259 |
| Otsuka America Pharmaceutical, Inc. | 11 | $177 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $166 |
| Lundbeck LLC | 4 | $98 |
| Supernus Pharmaceuticals, Inc. | 3 | $57 |
| Neurocrine BioSciences, Inc. | 2 | $56 |
| Corium, LLC | 2 | $56 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $49 |
Products named: REXULTI, VRAYLAR, Auvelity, Onyda XR, TRINTELLIX, Qelbree, INGREZZA, Azstarys.
Industry payments across TX — which companies pay providers there.
